Avanos Medical Names 2 New Execs

Avanos Medical has made two new executive leadership appointments.
 
Michael Greiner has been made chief transformation officer, in addition to his current responsibilities as senior VP and CFO. Kerr Holbrook was named senior VP and chief commercial officer.
 
“Our global teams have been working diligently to identify changes that will allow us to reimagine our business and create sustainable value for both internal and external stakeholders,” Joe Woody, Avanos CEO told the press. “We have established the groundwork for a three-year transformation aimed at optimizing our commercial organization and enhancing our financial performance. Our chief financial officer, Michael Greiner—who has led many of our efforts in margin improvement, M&A, and free cash flow generation—will take on the additional and newly created role of chief transformation officer. In that position, he will lead our transformation efforts as we remain focused on achieving our strategic and financial priorities.”
 
Avanos will put the North America Chronic Care and Pain franchise functions under one organization, led by Kerr Holbrook in his newly created roles of senior VP and chief commercial officer. Holbrook joined Avanos in 2019 as senior VP and GM of the company’s Chronic Care franchise. Before Avanos, he was chief commercial officer at AlloSource.
 
“I’m enthusiastic about the many benefits this new structure is expected to bring to Avanos, including improved best-practice sharing, a more consistent strategic approach, and an enhanced ability to scale critical functions like digital marketing and strategic analytics,” said Holbrook. “With twin goals of accelerating sales and improving our commercial impact, our unified commercial organization is designed to help us drive efficiencies and focus on core categories and channels.”